Kevin M. Nelson’s Perspectives

55 total results. Page 4 of 5.

Alerts
If Successful, Teva Suit Could Decrease Generic Competition
Alerts
Clinical Trial Impact from Coronavirus: New FDA Guidelines for Safety and Integrity
Events
Inherent Obviousness: A Case Study on a Less Known but Effective Defense
News
Drug Approval Law Will Likely Deter Pharma Delay Tactics
Press Release
Eighty-Eight Attorneys Named to 2020 Leading Lawyers
Alerts
Congress CREATES a New Action to Combat Drug Approval Delays
Press Release
Thirty-Two Attorneys Named to 2020 Super Lawyers and Rising Stars Lists
News
Nelson Featured on Challenges to Biosimilar Development and Accessibility
News
Nelson Quoted on the Effect of Unexpected Biosimilar Launches on Drug Licensing Agreements
News
What if Pfizer Could Donate Data to NIH? One Proposal to Promote Public Good
News
Nelson Quoted on U.S. House Bill to Curb Patent Evergreening
News
Time To Create A Viable Path To Biosimilar Interchangeability